News/Events/Local Blog
Research News
Latest – National Research News Feed
In a new study, researchers reviewed the advancements and ongoing challenges in the development of biologic therapies and disease prognosis of pediatric rheumatic diseases over...
Read more
Published on: 2024-12-19
Source:
Lupus News & Events
In a new study, researchers evaluated the treatment effects of BI655064, an anti-CD40 monoclonal antibody, as an add-on therapy for people living with lupus nephritis...
Read more
Published on: 2024-12-13
Source:
Lupus News & Events
Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with moderate-to-severe systemic lupus erythematosus (SLE). The ongoing trial is evaluating safety, pharmacokinetics,...
Read more
Published on: 2024-12-12
Source:
Lupus News & Events
In a new study published in Lupus Science & Medicine, researchers found a connection between renal (kidney) response and long-term renal outcomes. People with lupus...
Read more
Published on: 2024-12-06
Source:
Lupus News & Events
In a new study, researchers surveyed people living with systemic lupus erythematosus (SLE) to examine if demographic factors such as age, race/ethnicity, and geographic location,...
Read more
Published on: 2024-12-06
Source:
Lupus News & Events
Researchers explored the connection between systemic lupus erythematosus (SLE) and thyroid (a gland in the body that produces hormones regulating metabolism and growth) disorders and...
Read more
Published on: 2024-12-06
Source:
Lupus News & Events
The U.S Food and Drug Administration (FDA) granted Fast Track Designation to Sana Biotechnology’s SC291 for relapsed/refractory systemic lupus erythematosus (SLE) treatment. SC291 is a hypoimmune...
Read more
Published on: 2024-12-05
Source:
Lupus News & Events
The National Football League’s (NFL) My Cause My Cleats campaign is back for its ninth year, allowing players to turn their passion for advocacy into...
Read more
Published on: 2024-12-05
Source:
Lupus News & Events
Lupus News & Events
National Lupus News & Events Feed
Jessica was thriving - she had moved into her first home, a cozy space that mirrored her vibrant personality and aspirations. Her career was flourishing,...
Read more
Published on: 2024-12-17
Source:
Lupus News & Events
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and groundbreaking discoveries in lupus research. The annual meeting, held from...
Read more
Published on: 2024-11-19
Source:
Lupus News & Events
How do I explain to a 9 year old that I cannot do all the things we used to do before or spend as much...
Read more
Published on: 2024-11-14
Source:
Lupus News & Events
Each year, Medicare beneficiaries are given the opportunity to select a new plan for the upcoming year during the Open Enrollment Period. This year, Open...
Read more
Published on: 2024-11-01
Source:
Lupus News & Events
This Hispanic Heritage Month, we celebrate the strength, culture, and contribution of the Hispanic and Latino communities across the country. As we celebrate these vibrant...
Read more
Published on: 2024-10-15
Source:
Lupus News & Events
Each year, Medicare beneficiaries are given the opportunity to select a new plan for the upcoming year during the Open Enrollment Period. This year, Open...
Read more
Published on: 2024-10-08
Source:
Lupus News & Events
A Life-Changing DiagnosisIn September 2009, Shannon Small's life took an unexpected turn when she was diagnosed with lupus nephritis, lupus-related kidney disease. At the time,...
Read more
Published on: 2024-08-14
Source:
Lupus News & Events
- By Teri Yoder, Vice President of Development and FundraisingA will is one of the most important legal documents you’ll ever make, and if you’re...
Read more
Published on: 2024-08-12
Source:
Lupus News & Events
Want the latest news delivered straight to your e-mail inbox?
Newsletter Subscription
Subscribe to our newsletter to recive the latest news, research studies, Local events, stories, helpful tool, and so much more.